Global Infectious Diseases Market Research Report 2018 Opportunities, Size, Cost Structure, Service Provider, Segmentation, Shares, Forecast to 2024

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Aug-2018   |    Format :PDF   |    Number of Pages : 102
This report studies the global Infectious Diseases market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Infectious Diseases market by companies, region, type and end-use industry.

When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antiprotozoal and antihelminthic) agents.
Depending on the severity and the type of infection, the antibiotic may be given by mouth or by injection, or may be applied topically. Severe infections of the brain are usually treated with intravenous antibiotics. Sometimes, multiple antibiotics are used in case there is resistance to one antibiotic.
In 2017, the global Infectious Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global top players, covered
    F. Hoffmann-La Roche
    Gilead Sciences
    GlaxoSmithKline
    Johnson & Johnson
    Merck
    Pfizer
    AbbVie
    Astellas Pharma
    AstraZeneca
    Bayer
    Bristol-Myers Squibb
    Chimerix Pharmaceuticals
    Cubist
    Eli Lilly
    Isis Pharmaceuticals
    Mitsubishi Tanabe Pharma
    Novartis
    Sanofi
    Vertex   

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India

Market segment by Type, the product can be split into
    Antibacterial drugs
    Antiviral drugs
    Antifungal drugs
    Antiparasitic drugs

Market segment by Application, split into
    Acquired Immune Deficiency Syndrome
    Hepatitis B
    Hepatitis C
    Human Papillomavirus
    Hospital acquired Methicillin-resistant Staphylococcus aureus infection
    Chlamydia trachomatis and Neisseria Gonorrhea

The study objectives of this report are:
    To study and forecast the market size of Infectious Diseases in global market.
    To analyze the global key players, SWOT analysis, value and global market share for top players.
    To define, describe and forecast the market by type, end use and region.
    To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
    To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Infectious Diseases are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Infectious Diseases Manufacturers
Infectious Diseases Distributors/Traders/Wholesalers
Infectious Diseases Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Infectious Diseases market, by end-use.
Detailed analysis and profiles of additional market players.

Global Infectious Diseases Market Size, Status and Forecast 2025
1 Industry Overview of Infectious Diseases
    1.1  Infectious Diseases Market Overview
        1.1.1 Infectious Diseases Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Infectious Diseases Market Size and Analysis by Regions (2013-2018)
        1.2.1 United States
        1.2.2 Europe
        1.2.3 China
        1.2.4 Japan
        1.2.5 Southeast Asia
        1.2.6 India
    1.3 Infectious Diseases Market by Type
        1.3.1 Antibacterial drugs
        1.3.2 Antiviral drugs
        1.3.3 Antifungal drugs
        1.3.4 Antiparasitic drugs
    1.4 Infectious Diseases Market by End Users/Application
        1.4.1 Acquired Immune Deficiency Syndrome
        1.4.2 Hepatitis B
        1.4.3 Hepatitis C
        1.4.4 Human Papillomavirus
        1.4.5 Hospital acquired Methicillin-resistant Staphylococcus aureus infection
        1.4.6 Chlamydia trachomatis and Neisseria Gonorrhea

2 Global Infectious Diseases Competition Analysis by Players
    2.1 Infectious Diseases Market Size (Value) by Players (2013-2018)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 F. Hoffmann-La Roche
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Infectious Diseases Revenue (Million USD) (2013-2018)
    3.2 Gilead Sciences
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Infectious Diseases Revenue (Million USD) (2013-2018)
    3.3 GlaxoSmithKline
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Infectious Diseases Revenue (Million USD) (2013-2018)
    3.4 Johnson & Johnson
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Infectious Diseases Revenue (Million USD) (2013-2018)
    3.5 Merck
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Infectious Diseases Revenue (Million USD) (2013-2018)
    3.6 Pfizer
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Infectious Diseases Revenue (Million USD) (2013-2018)
    3.7 AbbVie
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Infectious Diseases Revenue (Million USD) (2013-2018)
    3.8 Astellas Pharma
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Infectious Diseases Revenue (Million USD) (2013-2018)
    3.9 AstraZeneca
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Infectious Diseases Revenue (Million USD) (2013-2018)
    3.10 Bayer
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Infectious Diseases Revenue (Million USD) (2013-2018)
    3.11 Bristol-Myers Squibb
    3.12 Chimerix Pharmaceuticals
    3.13 Cubist
    3.14 Eli Lilly
    3.15 Isis Pharmaceuticals
    3.16 Mitsubishi Tanabe Pharma
    3.17 Novartis
    3.18 Sanofi
    3.19 Vertex   

4 Global Infectious Diseases Market Size by Type and Application (2013-2018)
    4.1 Global Infectious Diseases Market Size by Type (2013-2018)
    4.2 Global Infectious Diseases Market Size by Application (2013-2018)
    4.3 Potential Application of Infectious Diseases in Future
    4.4 Top Consumer/End Users of Infectious Diseases

5 United States Infectious Diseases Development Status and Outlook
    5.1 United States Infectious Diseases Market Size (2013-2018)
    5.2 United States Infectious Diseases Market Size and Market Share by Players (2013-2018)
    5.3 United States Infectious Diseases Market Size by Application (2013-2018)

6 Europe Infectious Diseases Development Status and Outlook
    6.1 Europe Infectious Diseases Market Size (2013-2018)
    6.2 Europe Infectious Diseases Market Size and Market Share by Players (2013-2018)
    6.3 Europe Infectious Diseases Market Size by Application (2013-2018)

7 China Infectious Diseases Development Status and Outlook
    7.1 China Infectious Diseases Market Size (2013-2018)
    7.2 China Infectious Diseases Market Size and Market Share by Players (2013-2018)
    7.3 China Infectious Diseases Market Size by Application (2013-2018)

8 Japan Infectious Diseases Development Status and Outlook
    8.1 Japan Infectious Diseases Market Size (2013-2018)
    8.2 Japan Infectious Diseases Market Size and Market Share by Players (2013-2018)
    8.3 Japan Infectious Diseases Market Size by Application (2013-2018)

9 Southeast Asia Infectious Diseases Development Status and Outlook
    9.1 Southeast Asia Infectious Diseases Market Size (2013-2018)
    9.2 Southeast Asia Infectious Diseases Market Size and Market Share by Players (2013-2018)
    9.3 Southeast Asia Infectious Diseases Market Size by Application (2013-2018)

10 India Infectious Diseases Development Status and Outlook
    10.1 India Infectious Diseases Market Size (2013-2018)
    10.2 India Infectious Diseases Market Size and Market Share by Players (2013-2018)
    10.3 India Infectious Diseases Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
    11.1 Global Infectious Diseases Market Size (Value) by Regions (2018-2025)
        11.1.1 United States Infectious Diseases Revenue and Growth Rate (2018-2025)
        11.1.2 Europe Infectious Diseases Revenue and Growth Rate (2018-2025)
        11.1.3 China Infectious Diseases Revenue and Growth Rate (2018-2025)
        11.1.4 Japan Infectious Diseases Revenue and Growth Rate (2018-2025)
        11.1.5 Southeast Asia Infectious Diseases Revenue and Growth Rate (2018-2025)
        11.1.6 India Infectious Diseases Revenue and Growth Rate (2018-2025)
    11.2 Global Infectious Diseases Market Size (Value) by Type (2018-2025)
    11.3 Global Infectious Diseases Market Size by Application (2018-2025)

12 Infectious Diseases Market Dynamics
    12.1 Infectious Diseases Market Opportunities
    12.2 Infectious Diseases Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Infectious Diseases Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Infectious Diseases Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source



List of Tables and Figures

    Figure Global Infectious Diseases Market Size (Million USD) Status and Outlook (2013-2018)
    Table Global Infectious Diseases Revenue (Million USD) Comparison by Regions (2013-2018)
    Figure Global Infectious Diseases Market Share by Regions (2013-2018)
    Figure United States Infectious Diseases Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Europe Infectious Diseases Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure China Infectious Diseases Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Japan Infectious Diseases Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Southeast Asia Infectious Diseases Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure India Infectious Diseases Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Global Infectious Diseases Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
    Figure Global Infectious Diseases Revenue Market Share by Type in 2017
    Figure Antibacterial drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Antiviral drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Antifungal drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Antiparasitic drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Global Infectious Diseases Market Share by Application in 2017
    Figure Infectious Diseases Market Size (Million USD) and Growth Rate in Acquired Immune Deficiency Syndrome (2013-2018)
    Figure Infectious Diseases Market Size (Million USD) and Growth Rate in Hepatitis B (2013-2018)
    Figure Infectious Diseases Market Size (Million USD) and Growth Rate in Hepatitis C (2013-2018)
    Figure Infectious Diseases Market Size (Million USD) and Growth Rate in Human Papillomavirus (2013-2018)
    Figure Infectious Diseases Market Size (Million USD) and Growth Rate in Hospital acquired Methicillin-resistant Staphylococcus aureus infection (2013-2018)
    Figure Infectious Diseases Market Size (Million USD) and Growth Rate in Chlamydia trachomatis and Neisseria Gonorrhea (2013-2018)
    Table Infectious Diseases Market Size (Million USD) by Players (2013-2018)
    Figure Infectious Diseases Market Size Share by Players in 2013
    Figure Infectious Diseases Market Size Share by Players in 2017
    Table F. Hoffmann-La Roche Basic Information List
    Table Infectious Diseases Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
    Figure F. Hoffmann-La Roche Infectious Diseases Business Revenue Market Share (2013-2018)
    Table Gilead Sciences Basic Information List
    Table Infectious Diseases Business Revenue (Million USD) of Gilead Sciences (2013-2018)
    Figure Gilead Sciences Infectious Diseases Business Revenue Market Share (2013-2018)
    Table GlaxoSmithKline Basic Information List
    Table Infectious Diseases Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
    Figure GlaxoSmithKline Infectious Diseases Business Revenue Market Share (2013-2018)
    Table Johnson & Johnson Basic Information List
    Table Infectious Diseases Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
    Figure Johnson & Johnson Infectious Diseases Business Revenue Market Share (2013-2018)
    Table Merck Basic Information List
    Table Infectious Diseases Business Revenue (Million USD) of Merck (2013-2018)
    Figure Merck Infectious Diseases Business Revenue Market Share (2013-2018)
    Table Pfizer Basic Information List
    Table Infectious Diseases Business Revenue (Million USD) of Pfizer (2013-2018)
    Figure Pfizer Infectious Diseases Business Revenue Market Share (2013-2018)
    Table AbbVie Basic Information List
    Table Infectious Diseases Business Revenue (Million USD) of AbbVie (2013-2018)
    Figure AbbVie Infectious Diseases Business Revenue Market Share (2013-2018)
    Table Astellas Pharma Basic Information List
    Table Infectious Diseases Business Revenue (Million USD) of Astellas Pharma (2013-2018)
    Figure Astellas Pharma Infectious Diseases Business Revenue Market Share (2013-2018)
    Table AstraZeneca Basic Information List
    Table Infectious Diseases Business Revenue (Million USD) of AstraZeneca (2013-2018)
    Figure AstraZeneca Infectious Diseases Business Revenue Market Share (2013-2018)
    Table Bayer Basic Information List
    Table Infectious Diseases Business Revenue (Million USD) of Bayer (2013-2018)
    Figure Bayer Infectious Diseases Business Revenue Market Share (2013-2018)
    Table Bristol-Myers Squibb Basic Information List
    Table Infectious Diseases Business Revenue (Million USD) of Bristol-Myers Squibb (2013-2018)
    Figure Bristol-Myers Squibb Infectious Diseases Business Revenue Market Share (2013-2018)
    Table Chimerix Pharmaceuticals Basic Information List
    Table Infectious Diseases Business Revenue (Million USD) of Chimerix Pharmaceuticals (2013-2018)
    Figure Chimerix Pharmaceuticals Infectious Diseases Business Revenue Market Share (2013-2018)
    Table Cubist Basic Information List
    Table Eli Lilly Basic Information List
    Table Isis Pharmaceuticals Basic Information List
    Table Mitsubishi Tanabe Pharma Basic Information List
    Table Novartis Basic Information List
    Table Sanofi Basic Information List
    Table Vertex    Basic Information List
    Table Global Infectious Diseases Market Size (Million USD) by Product (2013-2018)
    Figure Global Infectious Diseases Revenue Market Share (%) by Product (2013-2018)
    Figure Global Infectious Diseases Market Share by Product in 2017
    Table Global Infectious Diseases Market Size by Application (2013-2018)
    Figure Global Infectious Diseases Revenue Market Share (%) by Application in 2017
    Table Top Consumer/End Users of Infectious Diseases
    Figure United States Infectious Diseases Market Size (Million USD) and Growth Rate (2013-2018)
    Table United States Infectious Diseases Market Size (Million USD) by Players (2013-2018)
    Figure United States Infectious Diseases Market Size Share by Players in 2013
    Figure United States Infectious Diseases Market Size Share by Players in 2017
    Table United States Infectious Diseases Market Size by Application (2013-2018)
    Figure United States Infectious Diseases Revenue Market Share (%) by Application (2013-2018)
    Figure United States Infectious Diseases Market Size Share by Application in 2017
    Figure Europe Infectious Diseases Market Size (Million USD) and Growth Rate (2013-2018)
    Table Europe Infectious Diseases Market Size (Million USD) by Players (2013-2018)
    Figure Europe Infectious Diseases Market Size Share by Players in 2013
    Figure Europe Infectious Diseases Market Size Share by Players in 2017
    Table Europe Infectious Diseases Market Size by Application (2013-2018)
    Figure Europe Infectious Diseases Revenue Market Share (%) by Application (2013-2018)
    Figure Europe Infectious Diseases Market Size Share by Application in 2017
    Figure China Infectious Diseases Market Size (Million USD) and Growth Rate (2013-2018)
    Table China Infectious Diseases Market Size (Million USD) by Players (2013-2018)
    Figure China Infectious Diseases Market Size Share by Players in 2013
    Figure China Infectious Diseases Market Size Share by Players in 2017
    Table China Infectious Diseases Market Size by Application (2013-2018)
    Figure China Infectious Diseases Revenue Market Share (%) by Application (2013-2018)
    Figure China Infectious Diseases Market Size Share by Application in 2017
    Figure Japan Infectious Diseases Market Size (Million USD) and Growth Rate (2013-2018)
    Table Japan Infectious Diseases Market Size (Million USD) by Players (2013-2018)
    Figure Japan Infectious Diseases Market Size Share by Players in 2013
    Figure Japan Infectious Diseases Market Size Share by Players in 2017
    Table Japan Infectious Diseases Market Size by Application (2013-2018)
    Figure Japan Infectious Diseases Revenue Market Share (%) by Application (2013-2018)
    Figure Japan Infectious Diseases Market Size Share by Application in 2017
    Figure Southeast Asia Infectious Diseases Market Size (Million USD) and Growth Rate (2013-2018)
    Table Southeast Asia Infectious Diseases Market Size (Million USD) by Players (2013-2018)
    Figure Southeast Asia Infectious Diseases Market Size Share by Players in 2013
    Figure Southeast Asia Infectious Diseases Market Size Share by Players in 2017
    Table Southeast Asia Infectious Diseases Market Size by Application (2013-2018)
    Figure Southeast Asia Infectious Diseases Revenue Market Share (%) by Application (2013-2018)
    Figure Southeast Asia Infectious Diseases Market Size Share by Application in 2017
    Figure India Infectious Diseases Market Size (Million USD) and Growth Rate (2013-2018)
    Table India Infectious Diseases Market Size (Million USD) by Players (2013-2018)
    Figure India Infectious Diseases Market Size Share by Players in 2013
    Figure India Infectious Diseases Market Size Share by Players in 2017
    Table India Infectious Diseases Market Size by Application (2013-2018)
    Figure India Infectious Diseases Revenue Market Share (%) by Application (2013-2018)
    Figure India Infectious Diseases Market Size Share by Application in 2017
    Figure Global Infectious Diseases Market Size and Growth Rate (2018-2025)
    Table Global Infectious Diseases Market Size (Million USD) by Regions (2018-2025)
    Figure Global Infectious Diseases Market Size Share (2018-2025)
    Figure Global Infectious Diseases Market Size Share by Regions in 2025
    Figure United States Infectious Diseases Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Europe Infectious Diseases Revenue (Million USD) and Growth Rate (2018-2025)
    Figure China Infectious Diseases Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Japan Infectious Diseases Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Southeast Asia Infectious Diseases Revenue (Million USD) and Growth Rate (2018-2025)
    Figure India Infectious Diseases Revenue (Million USD) and Growth Rate (2018-2025)
    Table Global Infectious Diseases Market Size (Million USD) by Type (2018-2025)
    Figure Global Infectious Diseases Market Size Share by Type in 2018
    Figure Global Infectious Diseases Market Size Share by Type in 2025
    Table Global Infectious Diseases Market Size (Million USD) by Application (2018-2025)
    Figure Global Infectious Diseases Market Size (Million USD) by Application in 2018

Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...